CETUXIMAB
Predictive Biomarkers for Monoclonal Antibody Therapies Targeting EGFR ( Cetuximab, Panitumumab) in the Treatment of Metastatic Colorectal Cancer | IntechOpen
SMPDB
Targeted biotherapy in metastatic colorectal carcinoma: Current practice - ScienceDirect
Frontiers | Distinguishing Features of Cetuximab and Panitumumab in Colorectal Cancer and Other Solid Tumors | Oncology
Management of BRAF-mutant metastatic colorectal cancer: a review of treatment options and evidence-based guidelines - Annals of Oncology
Mechanisms of action of cetuximab. (A) Cetuximab has a higher affinity... | Download Scientific Diagram
EGFR signalling and action mechanism of cetuximab. | Download Scientific Diagram
Resistance to anti-EGFR therapies in metastatic colorectal cancer: underlying mechanisms and reversal strategies | Journal of Experimental & Clinical Cancer Research | Full Text
University Hospital Gasthuisberg, Leuven, Belgium - ppt download
Panitumumab - Dubois - 2009 - British Journal of Clinical Pharmacology - Wiley Online Library
Cancers | Free Full-Text | Overcoming Intrinsic and Acquired Cetuximab Resistance in RAS Wild-Type Colorectal Cancer: An In Vitro Study on the Expression of HER Receptors and the Potential of Afatinib
Integrating anti-EGFR therapies in metastatic colorectal cancer - Haraldsdottir - Journal of Gastrointestinal Oncology
Beyond EGFR inhibition: multilateral combat strategies to stop the progression of head and neck cancer | Experimental & Molecular Medicine
Cetuximab - an overview | ScienceDirect Topics
Cetuximab-Triptolide Conjugate Suppresses the Growth of EGFR-Overexpressing Lung Cancers through Targeting RNA Polymerase II: Molecular Therapy - Oncolytics
Cetuximab combined with radiotherapy: An alternative to chemoradiotherapy for patients with locally advanced squamous cell carcinomas of the head and neck? - European Journal of Cancer
The mechanism of cetuximab action. Notes: Schematic representation of... | Download Scientific Diagram
First-line targeted therapies in the treatment of metastatic colorectal cancer - role of cetuximab. - Abstract - Europe PMC
Cetuximab | Nature Reviews Drug Discovery
Mechanisms of action of EGFR inhibitors | EGFR Inhibitors in Cancer Treatment
Erbitux Mechanism of Action
Table 3 from A Novel Anti-EGFRMonoclonal Antibody , Cetuximab(Erbitux R ) | Semantic Scholar
2: Mode of action of Cetuximab. The epidermal growth factor receptor... | Download Scientific Diagram
Immune biomarkers of anti-EGFR monoclonal antibody therapy - Annals of Oncology
ERBITUX (cetuximab) for Head and Neck Cancer and Colorectal Cancer - Cancer Therapy Advisor
